Skip to main content
SpringerLink
Log in

Valuing cancer care: value frameworks poorly correlated

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

References

  1. Del Paggio JC, et al. Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks. Lancet Oncology : 2 Jun 2017. Available from: URL: https://doi.org/10.1016/S1470-2045(17)30415-1.

  2. Evans WK, et al. Measuring value and benefit--a matter of perspective. Lancet Oncology : 2 Jun 2017. Available from: URL: https://doi.org/10.1016/S1470-2045(17)30423-0.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valuing cancer care: value frameworks poorly correlated. PharmacoEcon Outcomes News 780, 37 (2017). https://doi.org/10.1007/s40274-017-4089-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4089-2

Search

Navigation